Skip to main content
Equibles
ALGN logo

ALGN · Align Technology Inc · Metrics

Track ALGN — free

Use ALGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$150.55 +1.55 (+1.04%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.58B
Shares
71.04M
Volume · Oct 20 874.68K Avg daily vol (3M) 919.95K

ALGN metrics

109 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$149.00
Market cap
$10.58B

Price action

20 metrics
Price change (1W)
+6.1%
Price change (30D)
+1.4%
Price change (3M)
-14.9%
Price change (6M)
-22.3%
Price change (YTD)
-4.6%
Price change (1Y)
+14.2%
Trailing year
Price change (5Y)
-74.9%
52-week high
$197.51
52-week low
$131.91
Change from 52-week high
-24.6%
Change from 52-week low
+13.0%
Annualized volatility
39.3%
Annualized volatility (3M)
33.7%
Beta
1.4
RSI (14D)
52.5
Price vs SMA 50
-3.1%
Price vs SMA 200
-12.1%
Avg volume (3M)
919,951
Relative volume
0.8
Average dollar volume
$145.38M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
71.04M

Valuation

12 metrics
P / E (TTM)
26.0
Trailing earnings · reciprocal yield 3.9%
PEG ratio
—
EV / revenue
2.3×
reciprocal yield 43.8%
EV / EBITDA
11.8×
reciprocal yield 8.5%
EV / EBIT
17.3×
reciprocal yield 5.8%
P / sales
2.6×
reciprocal yield 39.2%
P / book
2.5
reciprocal yield 40.1%
FCF yield
6.0%
TTM · current market cap
Buyback yield
2.5%
P / FCF
16.7
reciprocal yield 6.0%
P / operating cash flow
14.0
reciprocal yield 7.2%
Earnings yield
3.9%

Historical valuation

8 metrics
P / E historical average (3Y)
35.3×
reciprocal yield 2.8%
P / E historical average (5Y)
43.9×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
3.5×
reciprocal yield 28.9%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.2%
EV / EBIT historical average (3Y)
22.8×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
27.7×
reciprocal yield 3.6%
EV / EBITDA historical average (3Y)
17.8×
reciprocal yield 5.6%
EV / EBITDA historical average (5Y)
22.7×
reciprocal yield 4.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
68.0%
Operating margin
13.2%
Trailing 12 months
Net margin
10.0%
Gross profit (TTM)
$2.82B
Operating profit (TTM)
$547.59M
Net income (TTM)
$413.58M
Trailing 12 months
Diluted EPS (TTM)
$5.74
FCF margin
15.3%
Effective tax rate
27.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$57.64
Gross profit per diluted share (TTM)
$39.23
Operating profit per diluted share (TTM)
$7.63
EBITDA per diluted share (TTM)
$11.17
Net income per diluted share (TTM)
$5.76
Operating cash flow per diluted share (TTM)
$10.52
Free cash flow per diluted share (TTM)
$8.82
Capital expenditures per diluted share (TTM)
$1.70
R&D per diluted share (TTM)
$5.25
Stock compensation per diluted share (TTM)
$2.49
Book value per share
$56.74

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
-13.1%
Revenue (TTM)
$4.14B
Trailing 12 months
EPS growth YoY
-12.2%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+10.3%
EPS CAGR (3Y)
+7.0%
EPS CAGR (5Y)
-24.1%
FCF CAGR (3Y)
+21.0%
FCF CAGR (5Y)
-0.7%

Quality

14 metrics
Return on equity
9.8%
Return on assets
6.4%
Debt / equity
0.0
Current ratio
1.4
EBITDA (TTM)
$801.98M
Free cash flow (TTM)
$633.57M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
-1.4
Return on invested capital
12.7%
Trailing 12 months
Net cash
$1.10B
Latest balance sheet
Cash & equivalents
$1.10B
Total assets
$6.42B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$755.70M
Capital expenditures (TTM)
$122.13M
R&D (TTM)
$377.00M
SG&A (TTM)
$1.79B
Stock compensation (TTM)
$179.15M
R&D / revenue
9.1%
Stock compensation / revenue
4.3%

Ownership (13F)

9 metrics
13F filers
682
13F filer change QoQ
-19
Institutional ownership
103.7%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.3%
Holder tenure
17.2
Price vs estimated holder cost
-7.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
20.2%

Short interest

3 metrics
Short interest
5.9%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1097149 CUSIP 016255101 13F (30d) 78 filings 73 filers Visit website Investor relations